First-ever FDA approved PROTAC supports the further development and potential of Arvinas’ pipeline –– Announced FDA Approval of VEPPANU™ ...
Key opportunities in the Global Traffic Management market include the integration of AI, IoT, and big data for real-time traffic optimization, the shift towards cloud-based models for scalability, and ...
Company closed PIPE financing with gross proceeds of up to $175 million, including the possible exercise of warrants, from long-term global investors. Proceeds are expected to fund the Company through ...
ProMIS Neurosciences Inc. , a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases, ...
Akari’s lead program, AKTX-101, a TROP2-targeting ADC powered by its proprietary PH1 payload, is currently in IND-enabling ...
Vietnam’s offshore oil and gas sector has achieved world-class technological standards, but much of the country’s marine ...
First Quarter Revenue of $58.4 million Net loss of $10.7 million Consolidated AEBITDA of $3.6 millionLAS VEGAS--(BUSINESS WIRE)--PLAYSTUDIOS, Inc. (NASDAQ: MYPS) (“PLAYSTUDIOS” or the “Company”), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results